Posted on

Johnson & Johnson Requests Emergency Use Authorization from FDA for One Dose COVID Vaccine

64310182 10156106202320951 9163112232647655424 n

 

the staff of the Ridgewood blog

New Brunswick NJ,  Johnson & Johnson (NYSE: JNJ) (the Company) today announced that Janssen Biotech, Inc., has submitted an application to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for its investigational single-dose Janssen COVID-19 vaccine candidate. The Company’s EUA submission is based on topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose vaccine met all primary and key secondary endpoints. The Company expects to have product available to ship immediately following authorization.

Continue reading Johnson & Johnson Requests Emergency Use Authorization from FDA for One Dose COVID Vaccine